Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2011

01-09-2011 | Original Paper

Primary cardiac pheochromocytoma with Multiple Endocrine Neoplasia

Authors: Chaoji Zhang, Guotao Ma, Xingrong Liu, Heng Zhang, Haibo Deng, Justin Nowell, Qi Miao

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2011

Login to get access

Abstract

Purpose

Cardiac pheochromocytoma with multiple endocrine neoplasia syndrome (MENS) is rare. We present a rare case of concurrent cardiac pheochromocytoma and pituitary adenoma, a rare variant of the MEN syndromes and a review of the literature with special emphasis on diagnosis and treatment.

Methods

Different from the single MENS type I or type II, Variant MENS’ symptoms and signs are so nontypical that it is easy to make a misdiagnosis or missed diagnosis. One patient with variant MENS was treated surgically and relevant case data were collected.

Results

The perioperative course was uneventful. At 24-month follow-up, catecholamine levels returned to normal and no symptoms of pheochromocytoma was found.

Conclusions

Cardiac pheochromocytoma with Multiple Endocrine Neoplasia can be treated by operation with good prognosis. Surgical removal to provide relief or effective control of symptoms is the treatment of choice.
Literature
go back to reference Breckenridge SM, Hamrahian AH, Faiman C, Suh J, Prayson R, Mayberg M (2003) Coexistence of a pituitary macroadenoma and pheochromocytoma–a case report and review of the literature. Pituitary 6:221–225PubMedCrossRef Breckenridge SM, Hamrahian AH, Faiman C, Suh J, Prayson R, Mayberg M (2003) Coexistence of a pituitary macroadenoma and pheochromocytoma–a case report and review of the literature. Pituitary 6:221–225PubMedCrossRef
go back to reference Falchetti A, Marini F, Luzi E, Tonelli F, Brandi ML (2008) Multiple endocrine neoplasms. Best Pract Res Clin Rheumatol 22(1):149–163PubMedCrossRef Falchetti A, Marini F, Luzi E, Tonelli F, Brandi ML (2008) Multiple endocrine neoplasms. Best Pract Res Clin Rheumatol 22(1):149–163PubMedCrossRef
go back to reference Grumbach MM, Biller BM, Braunstein GD (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424–429PubMed Grumbach MM, Biller BM, Braunstein GD (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424–429PubMed
go back to reference Lin JC, Palafox BA, Jackson HA, Cohen AJ, Gazzaniga AB (1999) Cardiac pheochromocytoma: resections after diagnosis by 111-indium octreotide scan. Ann Thorac Surg 67:555–558PubMedCrossRef Lin JC, Palafox BA, Jackson HA, Cohen AJ, Gazzaniga AB (1999) Cardiac pheochromocytoma: resections after diagnosis by 111-indium octreotide scan. Ann Thorac Surg 67:555–558PubMedCrossRef
go back to reference van der Harst E, de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SW et al (2001) [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas. J Clin Endocrinol Metab 86:685–693PubMedCrossRef van der Harst E, de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SW et al (2001) [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas. J Clin Endocrinol Metab 86:685–693PubMedCrossRef
go back to reference Yaylali GF, Akin F, Bastemir M, Yaylali YT, Ozden A (2008) Phaeochromocytoma combined with subclinical Cushing’s syndrome and pituitary microadenoma. Clin Invest Med 31:E176–E181PubMed Yaylali GF, Akin F, Bastemir M, Yaylali YT, Ozden A (2008) Phaeochromocytoma combined with subclinical Cushing’s syndrome and pituitary microadenoma. Clin Invest Med 31:E176–E181PubMed
Metadata
Title
Primary cardiac pheochromocytoma with Multiple Endocrine Neoplasia
Authors
Chaoji Zhang
Guotao Ma
Xingrong Liu
Heng Zhang
Haibo Deng
Justin Nowell
Qi Miao
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2011
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-011-0985-1

Other articles of this Issue 9/2011

Journal of Cancer Research and Clinical Oncology 9/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.